These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 8230286)

  • 1. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.
    Kaluzny A; Brawley O; Garson-Angert D; Shaw J; Godley P; Warnecke R; Ford L
    J Natl Cancer Inst; 1993 Dec; 85(23):1945-50. PubMed ID: 8230286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience.
    McCaskill-Stevens W; McKinney MM; Whitman CG; Minasian LM
    J Clin Oncol; 2005 Aug; 23(22):5247-54. PubMed ID: 16051967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance in quasi-firms: an example from the Community Clinical Oncology Program.
    Lacey LM; Hynes DM; Kaluzny AD
    J Health Hum Resour Adm; 1992; 14(3):307-26. PubMed ID: 10118501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing accrual in cancer clinical trials with a focus on minority enrollment: The William Beaumont Hospital Community Clinical Oncology Program Experience.
    Vicini F; Nancarrow-Tull J; Shah C; Chmielewski G; Fakhouri M; Sitarek SA; Feczko CT; Brzozowski C; Felten DL
    Cancer; 2011 Oct; 117(20):4764-71. PubMed ID: 21455995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the performance of a strategic alliance: an analysis of the Community Clinical Oncology Program.
    Kaluzny AD; Lacey LM; Warnecke R; Hynes DM; Morrissey J; Ford L; Sondik E
    Health Serv Res; 1993 Jun; 28(2):159-82. PubMed ID: 8514498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating organizational design to assure technology transfer: the case of the Community Clinical Oncology Program.
    Kaluzny AD; Ricketts T; Warnecke R; Ford L; Morrissey J; Gillings D; Sondik EJ; Ozer H; Goldman J
    J Natl Cancer Inst; 1989 Nov; 81(22):1717-25. PubMed ID: 2681795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accrual to the Breast Cancer Prevention Trial by participating Community Clinical Oncology Programs: a panel data analysis.
    Klabunde CN; Kaluzny AD
    Breast Cancer Res Treat; 1995 Jul; 35(1):43-50. PubMed ID: 7612903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using a community cancer treatment trials network for cancer prevention and control research: challenges and opportunities.
    Kaluzny AD; Lacey LM; Warnecke R; Morrissey JP; Sondik E; Ford L
    Cancer Epidemiol Biomarkers Prev; 1994; 3(3):261-9. PubMed ID: 8019377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing minority patient participation in cancer clinical trials using oncology nurse navigation.
    Holmes DR; Major J; Lyonga DE; Alleyne RS; Clayton SM
    Am J Surg; 2012 Apr; 203(4):415-22. PubMed ID: 21996347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provider-based research networks demonstrate greater hospice use for minority patients with lung cancer.
    Penn DC; Stitzenberg KB; Cobran EK; Godley PA
    J Oncol Pract; 2014 Jul; 10(4):e182-90. PubMed ID: 24781367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer control research for community programs: the National Cancer Institute initiative.
    Hunter CP; Bavier AR; Ford LG
    Cancer Detect Prev; 1990; 14(6):633-7. PubMed ID: 2257561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creating a "culture of research" in a community hospital: Strategies and tools from the National Cancer Institute Community Cancer Centers Program.
    Dimond EP; St Germain D; Nacpil LM; Zaren HA; Swanson SM; Minnick C; Carrigan A; Denicoff AM; Igo KE; Acoba JD; Gonzalez MM; McCaskill-Stevens W
    Clin Trials; 2015 Jun; 12(3):246-56. PubMed ID: 25691600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organizational and physician factors associated with patient enrollment in cancer clinical trials.
    Jacobs SR; Weiner BJ; Reeve BB; Weinberger M; Minasian LM; Good MJ
    Clin Trials; 2014 Oct; 11(5):565-75. PubMed ID: 24902923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustainability and performance of the National Cancer Institute's Community Clinical Oncology Program.
    Carpenter WR; Fortune-Greeley AK; Zullig LL; Lee SY; Weiner BJ
    Contemp Clin Trials; 2012 Jan; 33(1):46-54. PubMed ID: 21986391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials.
    Chen MS; Lara PN; Dang JH; Paterniti DA; Kelly K
    Cancer; 2014 Apr; 120 Suppl 7(0 7):1091-6. PubMed ID: 24643646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NCI Community Oncology Research Program: what every clinician needs to know.
    McCaskill-Stevens W; Lyss AP; Good M; Marsland T; Lilenbaum R
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials in the community. The community clinical oncology program experience.
    Cobau CD
    Cancer; 1994 Nov; 74(9 Suppl):2694-700. PubMed ID: 7954289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of managed care and competition on community-based clinical research.
    Carpenter WR; Weiner BJ; Kaluzny AD; Domino ME; Lee SY
    Med Care; 2006 Jul; 44(7):671-9. PubMed ID: 16799362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leveraging National Cancer Institute Programmatic Collaboration for Uterine Cervix Cancer Patient Accrual in Puerto Rico.
    Kunos CA; Massett HA; Galassi A; Walker JL; Good MJ; Díaz LB; McCaskill-Stevens W
    Front Oncol; 2018; 8():102. PubMed ID: 29692980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era.
    Roth ME; Unger JM; O'Mara AM; Lewis MA; Budd T; Johnson RH; Pollock BH; Blanke C; Freyer DR
    Cancer Med; 2020 Mar; 9(6):2146-2152. PubMed ID: 32009305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.